A well-timed bridge investment can mean the difference between stalling and scaling. Dr. Asel Sartbaeva, CEO and co-founder of EnsiliTech, reflects on how family office support provided crucial bridge, enabled better deal terms, and positioned the company to close an oversubscribed £4.5 million round.
2024 Showcase Finalist
Milestone - Bridge Funding
Funding
Family Office
Companion and Livestock
Biopharma
Seed
Prevention
Treatment

Asel Sartbaeva
CEO
EnsiliTech

Robert Hyde
Co-Founder and CTO
Vet Vision AI